Seizures of amphetamine-type stimulants (ATS) continue to grow globally, dominated by methamphetamine.
Quantities of ATS seized have increased more than for any other drug category, reaching a record 604 tons in 2024; methamphetamine dominates both seizures and dismantled laboratories, followed by amphetamine.
More synthetic cathinones under international control were seized over the 2020-2024 period (32.5 tons) than synthetic cathinones still falling under the NPS category (5.6 tons), suggesting that international control paves the way for law enforcement to undertake such seizures.
While ATS seizures have grown sharply, the number of laboratories reported to have been dismantled has fallen substantially over the past decade, primarily as a result of a strong decline in the number of small-scale methamphetamine laboratories and the apparent rise of large-scale laboratories (“super labs”) –accounting for a significant part of total illegal methamphetamine manufacture.
Regional seizure patterns remain highly distinct between 2020–2024:
Methamphetamine dominates in North America, Oceania, East and South-East Asia, South Asia, South-West Asia, East Africa and Southern Africa.
Amphetamine is the main ATS seized in the Near and Middle East and parts of Europe.
ATS seizures in most countries of the former Soviet Union are dominated by synthetic cathinones.
“Ecstasy” dominates ATS seizures in South America.